Court grants favorable decision to Warner Chilcott in Doryx dispute

A New Jersey court has granted a motion for preliminary injunction against Mylan ($MYL) preventing the company from launching a generic version of Doryx 150 mg before a decision is made in Warner Chilcott's ($WCRX) lawsuit against it. Warner Chilcott's suit maintains Mylan is infringing a patent covering the antibiotic. Warner Chilcott release

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.